Global medical device company, Polynovo
(ASX:PNV) has appointed Jean-Marcel Gielen as CFO and company secretary.
He will take up the position on the 12th of December after working as CFO at CardioScan for six years.
The announcement comes on the back of strong growth for the company's NovoSorb product, with full year sales reaching $1.74 million.
The company expects that in FY19 its US business will become profitable when sales reach $1 million a month.
Shares in Polynovo
(ASX:PNV) closed 0.84 per cent lower at $0.59 yesterday
